Selected article for: "receptor expression and significant increase"

Author: Méndez-Sánchez, Nahum; Valencia-Rodríguez, Alejandro; Qi, Xingshun; Yoshida, Eric M.; Romero-Gómez, Manuel; George, Jacob; Eslam, Mohammed; Abenavoli, Ludovico; Xie, Weifen; Teschke, Rolf; Carrion, Andres F.; Keaveny, Andrew P.
Title: What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist’s Perspective
  • Document date: 2020_4_11
  • ID: tiixwaqi_8
    Snippet: A recent mouse model of acute liver injury with partial hepatectomy found that at day 1 post-hepatectomy, hepatic expression of ACE2 in rats was downregulated. From day 3, there was an up to two-fold increased expression of this receptor, with a normalization of values on day 7, when the liver recovered and hepatocyte proliferation ceased. 17 With this information, the authors proposed that the systemic inflammation derived from significant NCP c.....
    Document: A recent mouse model of acute liver injury with partial hepatectomy found that at day 1 post-hepatectomy, hepatic expression of ACE2 in rats was downregulated. From day 3, there was an up to two-fold increased expression of this receptor, with a normalization of values on day 7, when the liver recovered and hepatocyte proliferation ceased. 17 With this information, the authors proposed that the systemic inflammation derived from significant NCP could trigger liver necrosis and hepatocyte proliferation, upregulating the expression of ACE2 and therefore worsening liver injury. Similarly, liver biopsies from SARS-CoV patients showed a significant increase in mitotic cell numbers, with eosinophilic bodies and balloon-like hepatocytes, 18 supporting a role for SARS-CoV-2 in the development of liver injury.

    Search related documents:
    Co phrase search for related documents
    • acute liver injury and liver biopsy: 1, 2, 3, 4, 5, 6
    • acute liver injury and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • acute liver injury and liver injury development: 1, 2, 3, 4, 5
    • acute liver injury and liver injury worsen: 1
    • acute liver injury and liver necrosis: 1
    • acute liver injury and mouse model: 1, 2, 3, 4, 5
    • acute liver injury and partial hepatectomy: 1, 2
    • acute liver injury and SARS role: 1, 2, 3
    • acute liver injury and significant increase: 1
    • acute liver injury and systemic inflammation: 1, 2, 3
    • acute liver injury mouse model and hepatocyte proliferation: 1, 2
    • acute liver injury mouse model and liver injury: 1, 2, 3
    • acute liver injury mouse model and mouse model: 1, 2, 3
    • acute liver injury mouse model and partial hepatectomy: 1, 2
    • acute liver injury mouse model and significant increase: 1
    • cell number and increase expression: 1, 2, 3, 4
    • cell number and liver biopsy: 1
    • cell number and liver injury: 1
    • cell number and liver necrosis: 1